Why ReVitt A?
Because we use breakthrough nano-liposomal technology. Administered intravenously, medication’s bioavailability (the fraction of an administered dose of unchanged drug that reaches the cells) is 100%. However, administered orally, it decreases to 5%, even as low as 1%.There are several factors that play a role in limiting the bioavailability: solubility of the compound,